Myriad Genetics (MYGN) Net Margin Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 191.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -482.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 405.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 89.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -237.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 4,443.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 3,776.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 89.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 30.00 |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 1,317.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,317.00 |
| Dec 31, 2025 | 2,003.00 |
| Sep 30, 2025 | 912.00 |
| Jun 30, 2025 | -14,723.00 |
| Mar 31, 2025 | 1,238.00 |
| Dec 31, 2024 | -1,545.00 |
| Sep 30, 2024 | -2,507.00 |
| Jun 30, 2024 | -1,487.00 |
| Mar 31, 2024 | 996.00 |
| Dec 31, 2023 | 184.00 |
| Sep 30, 2023 | 1,425.00 |
| Jun 30, 2023 | 310.00 |
| Mar 31, 2023 | 4,006.00 |
| Dec 31, 2022 | -1,954.00 |
| Sep 30, 2022 | -1,139.00 |
| Jun 30, 2022 | -587.00 |
| Mar 31, 2022 | -1,562.00 |
| Dec 31, 2021 | -593.00 |
| Sep 30, 2021 | 1,510.00 |
| Jun 30, 2021 | -996.00 |